Back

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

15 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Genomic insights into substance use and disinhibitory disorders
2026-02-09 genetic and genomic medicine 10.64898/2026.02.09.26344198
#1 (3.5%)
Show abstract

Externalizing spectrum disorders--spanning attention-deficit/hyperactivity disorder, conduct disorder, substance use disorders, and other disorders characterized by disinhibition--frequently co-occur within individuals due, in part, to shared genetic etiology. To advance understanding of this genetic architecture, we conducted a multi-ancestry, multivariate genome-wide association analysis of more than 4 million individuals, identifying 1,294 genomic regions linked to an externalizing factor. Fi...

2
Genome-wide genetic overlap between fear-based disorders and generalised anxiety disorder
2026-02-09 genetic and genomic medicine 10.64898/2026.02.06.26345742
Top 0.1% (2.6%)
Show abstract

Twin studies reveal high genetic overlap between anxiety disorders and depression, contributing to the internalising spectrum. Some genetic specificity for fear-based anxiety disorders (fear), distinct from general anxiety and depression (distress), has also emerged. Limited datasets with detailed phenotyping across anxiety disorders have restricted most genome-wide association studies (GWAS) to "any anxiety diagnosis". Additional genome-wide evidence to discern genetic differences between fear ...

3
Genetic Signal Augmentation of Childhood-Onset and Treatment-Resistant Major Depression Reveals Distinct Biological Disorders
2026-03-03 psychiatry and clinical psychology 10.64898/2026.03.02.26347449
Top 0.1% (2.0%)
Show abstract

Major depression (MD) is a disorder class that exhibits substantial phenotypic and clinical heterogeneity, yet many large-scale molecular genetic investigations treat MD as a unitary outcome. Here, we applied Genomic Structural Equation Modeling (Genomic SEM) to characterize the genetic variation in two clinically relevant MD subtypes, childhood-onset (child-onset) and treatment-resistant MD, that are independent of the field-standard GWAS of MD in all its forms. In addition, we fit a complement...

4
Plasma Lipid Alterations Track Multidimensional Psychosis Severity Across Diagnostic Boundaries
2026-02-26 psychiatry and clinical psychology 10.64898/2026.02.24.26346956
Top 0.2% (1.9%)
Show abstract

BackgroundLipidomic alterations have been reported across schizophrenia (SCZ) and bipolar disorder (BD), but findings are heterogeneous and often overlap across diagnoses, limiting diagnostic specificity. Associations between lipid profiles and illness severity have also been inconsistent when assessed using single symptom scales, raising the possibility that unidimensional measures fail to capture biologically relevant variation. Whether plasma lipidomic alterations relate to multidimensional p...

5
Diagnostic Accuracy and Clinical Reasoning of Multiple Large Language Models in Psychiatry
2026-02-09 psychiatry and clinical psychology 10.64898/2026.02.03.26345402
Top 0.2% (1.9%)
Show abstract

ImportanceLarge language models (LLMs) have demonstrated diagnostic potential in several medical specialties, but their application to psychiatry - where diagnosis relies heavily on clinical judgment, narrative interpretation, and reasoning under uncertainty - remains insufficiently evaluated. ObjectiveTo evaluate diagnostic accuracy and clinician-judged reasoning quality of multiple large language models using psychiatric case vignettes. DesignMixed-methods evaluation study of diagnostic accu...

6
Pathways from Polygenic Risk to Suicidality: Effects of Alcohol Use Disorder and Childhood Adversity
2026-02-12 genetic and genomic medicine 10.64898/2026.02.10.26345999
Top 0.3% (1.8%)
Show abstract

BackgroundThe prevalences of suicidal ideation (SI) and suicide attempt (SA) are influenced by genetic, behavioral, and environmental factors. Alcohol use disorder (AUD) and adverse childhood experiences (ACEs) may mediate or moderate genetic liability for suicidality. MethodsUsing data from 10,275 participants (43.8% female; 47.2% African-like genetic ancestry [AFR], 52.8% European-like genetic ancestry [EUR]), we tested whether polygenic scores (PGS) for SI and SA predicted lifetime SI or SA....

7
Biological embedding of the pyscho-social environment; an Epigenetic Analysis of Adversity from Early-life to Adulthood
2026-02-16 psychiatry and clinical psychology 10.64898/2026.02.13.26345039
Top 0.5% (1.5%)
Show abstract

IntroductionResearch has shown that social and physical stressors of early-life adversity (ELA) can negatively affect long-term health trajectories. Despite differences in types of ELA exposure, previous studies have identified common health-related outcomes in adults who had experienced less favourable conditions during developmentally sensitive periods. This meta-analysis investigates the potential role of DNA methylation in mediating these adverse health trajectories by identifying common bio...

8
Genetic evidence for repurposing immunomodulatory drugs for major depressive disorder
2026-02-09 psychiatry and clinical psychology 10.64898/2026.02.07.26345798
Top 0.5% (1.5%)
Show abstract

ObjectiveTo identify immunomodulatory drug targets with genetic evidence in major depressive disorder (MDD), probe symptom-level heterogeneity in their effects, and identify drug repurposing opportunities. MethodsWe used cis-Mendelian randomisation to evaluate the targets of 204 immunomodulatory compounds, including immunosuppressants, cytokine inhibitors, and anti-infectives. As exposures, we selected genetic instruments from nine genome-wide association studies (GWASs) of protein or gene tran...

9
Direct and Indirect Genetic Effects of Parental Liabilities to Mental Health Conditions and Related Traits on Children's Behavioural Difficulties: A Multi-Cohort Study
2026-02-12 psychiatry and clinical psychology 10.64898/2026.02.10.26345985
Top 0.8% (1.2%)
Show abstract

BackgroundParental genetics matters for childrens behavioural difficulties, but the extent to which this is due to direct genetic transmission versus environmentally mediated indirect genetic effects remains unclear. MethodsWe studied eight European birth cohorts with over 33,000 family-based trio samples. We analysed polygenic scores (PGSs) for 13 mental health and neurodevelopmental conditions and their composite indices (PC1 and mean) representing general neuropsychiatric liabilities, as wel...

10
Validation and Extension of a Risk Calculator to Predict Mood Recurrence in Young People with Bipolar Disorder
2026-03-02 psychiatry and clinical psychology 10.64898/2026.02.20.26346717
Top 0.9% (1.2%)
Show abstract

ObjectiveGiven the episodic nature of bipolar disorder (BD) and the variability in mood episode recurrence across individuals, accurate recurrence prediction is critical. The original COBY recurrence risk calculator (RC) was developed in a longitudinal youth cohort to estimate threshold recurrence risk. However, its accuracy for predicting subthreshold recurrences had not been fully evaluated. The objective of this study was to extend the previously developed COBY mood recurrence RC to predict b...

11
Psilocybin services and mental health outcomes within Oregon's state-regulated model
2026-02-19 psychiatry and clinical psychology 10.64898/2026.02.18.26346580
Top 0.9% (1.1%)
Show abstract

BackgroundIn 2020, Oregon became the first U.S. state to establish a regulated framework for adults to access psilocybin services using naturally-derived mushroom products. No studies have examined mental health outcomes among individuals receiving psilocybin in this context. AimsTo evaluate changes in self-reported symptoms of depression, anxiety, and well-being 30-days post-psilocybin session under the Oregon state-regulated model , and document session-related adverse events and doses consum...

12
Integrative transcriptomic analysis identifies long noncoding RNA dysregulation and circadian disruption in reward and executive circuits of opioid use disorder
2026-02-17 genetic and genomic medicine 10.64898/2026.02.14.26346327
Top 1.0% (1.1%)
Show abstract

Opioid use disorder (OUD) is characterized by compulsive drug seeking and impaired executive control arising from maladaptive plasticity within cortico-striatal circuits. While transcriptomic studies have identified coding gene alterations in the nucleus accumbens (NAc) and dorsolateral prefrontal cortex (DLPFC), the contribution of the noncoding genome remains poorly defined. Here, we performed integrative transcriptomic analysis of postmortem human NAc and DLPFC to systematically identify and ...

13
Suicide Risk of Third-Generation Antipsychotics in Persons with Schizophrenia and Schizoaffective Disorders: A Systematic Review and Meta-Analysis
2026-02-11 psychiatry and clinical psychology 10.64898/2026.02.10.26345876
Top 1% (1.1%)
Show abstract

Background and HypothesisClozapine is the only antipsychotic with protective effects against suicide in schizophrenia (SCZ). Newer third-generation antipsychotics (TGA) have better tolerability and modulate serotonin, dopamine, and N-methyl-d-aspartate neurotransmission pathways implicated in suicide. We aimed to investigate the effects of TGAs on suicide in SCZ. MethodsWe searched seven databases up to December 2023 for SCZ studies that reported suicide data. The primary outcome was suicide de...

14
Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis
2026-03-06 psychiatry and clinical psychology 10.64898/2026.03.05.26347694
Top 1% (1.1%)
Show abstract

Background At present, there are no approved pharmacological treatments for people at clinical high risk for psychosis (CHR-P). We sought to assess the acceptability of cannabidiol (CBD): a promising candidate treatment for this population. Methods CHR-P individuals completed a survey which assessed their views on the acceptability of CBD, its expected effectiveness and side effects, and on formulation preferences. Results The sample comprised 55 CHR-P individuals (24.3 years and 69% female). Mo...

15
Moderate to severe negative symptoms predict low risk of symptoms worsening in schizophrenia patients in CATIE
2026-02-10 psychiatry and clinical psychology 10.64898/2026.02.07.26345806
Top 1% (1.1%)
Show abstract

Understanding factors that predict the course of schizophrenia remains essential for improving long-term clinical management. Rate and severity of symptom exacerbations vary widely across individuals, and although prior studies have examined potential predictors, findings have been inconsistent and often limited by small samples, infrequent assessments, and non-standardized measures. Using data from phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE), which include...

16
Psychotherapies for obsessive-compulsive disorder have distinct effects on brain activity during emotional processing
2026-02-11 psychiatry and clinical psychology 10.64898/2026.02.10.26345974
Top 1% (1.1%)
Show abstract

BackgroundTo clarify the working mechanisms of psychotherapy for obsessive-compulsive disorder (OCD), we studied the neural effects of two psychotherapies: cognitive behavioral therapy with exposure and response prevention (CBT-ERP) and inference-based cognitive behavioral therapy (I-CBT). MethodsFifty-five individuals with OCD completed an emotional processing task during fMRI before and after 20 weekly psychotherapy sessions, using general fear and OCD-related visual stimuli. Forty-two health...

17
Longer Sleep Duration Predicts Progression to Bipolar or Psychotic Disorders in Youth accessing Early Intervention Mental Health Services
2026-03-05 psychiatry and clinical psychology 10.64898/2026.03.04.26347669
Top 1% (1.1%)
Show abstract

BackgroundWhile growing evidence implicates sleep-wake and circadian rhythm disturbances (SCRDs) in the onset and course of mood and psychotic disorders, longitudinal studies using objective measures are limited. This clinical cohort study examined whether actigraphy-derived SCRDs (sleep duration, timing, and efficiency) predicted transition to (i) any full-threshold mental disorders; and then specifically: (ii) full-threshold bipolar or psychotic disorders or (iii) other full-threshold (i.e. de...

18
Generating Biologically Relevant Subtypes of Autism Spectrum Disorder with differential responses to Acute Oxytocin Administration in a Randomized Trial using Random Forest Models and K-means Clustering
2026-02-14 psychiatry and clinical psychology 10.64898/2026.02.10.26346006
Top 1% (1.1%)
Show abstract

Autism Spectrum Disorder (ASD) is a heterogenous condition that has no biologically relevant subtypes yet. Here, we utilized a multidimensional approach considering social deficits in ASD alongside negative valence and empathy dysfunction to distinguish ASD from Neurotypicals (NT) and to generate ASD subtypes using machine learning approaches. 114 subjects were analyzed, with 70 being NT and 44 ASD, all male with an IQ greater than 70, with 5 domains of personality (NEO-PI-r) and Reading the Min...

19
Agreement between smartphone-based mobile sensing and actigraphy sleep metrics in young people with bipolar disorder
2026-03-02 psychiatry and clinical psychology 10.64898/2026.02.20.26346722
Top 1% (1.0%)
Show abstract

BackgroundSleep disturbance is a core feature of bipolar disorder (BD) and often precedes mood recurrence, particularly in youth. Although actigraphy provides objective sleep measurement, it is limited by cost and monitoring duration. Passive smartphone-based mobile sensing offers a scalable alternative, but its validity in youths with BD is unclear. MethodsAnalyses included adolescents and young adults (ages 14-25) with BD-I/II from the PROMPT-BD study with at least four days of concurrent act...

20
Lithium treatment after electroconvulsive therapy in bipolar disorder: A nationwide target trial emulation
2026-02-14 psychiatry and clinical psychology 10.64898/2026.02.11.26346116
Top 1% (1.0%)
Show abstract

ObjectivesElectroconvulsive Therapy (ECT) is an effective treatment for bipolar disorder, particularly in severe acute cases or for illness resistant to pharmacotherapy. However, the risk of relapse following ECT is high, necessitating intervention to reduce this risk. Based on findings from ECT studies in unipolar depression and its well-known mood-stabilizing properties, it is likely that lithium treatment may reduce the risk of relapse of bipolar disorder following ECT. Therefore, we conduct...